Pharmaceuticals

Your Content Goes Here

Posts in Category: Pharmaceuticals

Biosimilars Registration: SFDA Considerations
Published On: 16/03/2025By Regulatory Editor
How to write Economic Evaluation Studies (EES) for SFDA?
Published On: 14/01/2025By Madiha Baaj
Overview of SFDA Conditional Approval for New Medicines
Published On: 02/12/2024By Madiha Baaj
SFDA Drug Pricing Rules in Saudi Arabia
Published On: 30/11/2024By Rawd Alsubaie
CAR T Cell Registration in SFDA
Published On: 08/07/2024By Regulatory Editor
Breakthrough Medicines Designation in SFDA
Published On: 12/02/2024By Madiha Baaj
Orphan Drug Designation (ODD) in SFDA
Published On: 09/02/2024By Madiha Baaj
Drug Information and Stock Reporting to SFDA (SDI)
Published On: 10/01/2024By Rawd Alsubaie
Product Recall in Saudi Arabia
Published On: 29/09/2023By Nouf Almadallah
Medical Gas Registration
Published On: 06/05/2022By Heba Rasheed
SFDA Clinical Trials Requirements in Saudi Arabia
Published On: 23/04/2022By Nouf Almadallah
SFDA Variation Guidelines (Version 6.3)
Published On: 21/04/2021By Regulatory Editor

Regulatory Newsletter

Subscribe to receive the latest regulatory news and insights

Office Location

7164 Othman bn Affan Rd. Office No 13. Riyadh, 13317. Saudi Arabia.

Contact Us

Support@PharmaKnowl.com

+966-11-2777729

Business Hours

Sunday to Thursday:

9 am – 5 pm

© 2014 - 2025 • PharmaKnowl is a registered Trade Mark • All Content Rights are Reserved • Riyadh, Saudi Arabia

Contact Our Business Support Team

Sunday to Thursday: 9:00 am – 5:00 pm

+966 11 277 7729

+966 11 240 4409